Company intelligence / Profile preview

Yunnan Yongzitang Pharmaceutical Co., Ltd.

Zhaotong City, Yunnan Province, Chinaynyzt.com ↗
Ownership
Private
Employees
~250
Development stage
Other
01

Overview

Yunnan Yongzitang Pharmaceutical is a pharmaceutical company specializing in traditional Chinese medicine, with at least one nationally approved product for headache and memory disorders. The company owns several national exclusive TCM patents, reported significant profits as of 2013, and was acquired by Hunan Hansen Pharmaceutical, which now holds an 80% stake. Its lead product is rhizome gastrodiae capsules.

Therapeutic areas
Neurology
Modalities
Herbal medicineSmall molecules
Industry
Biotech
02

Drug pipeline

10 assets

tianma xingnao jiaonang

Unknown

9 more assets in the full pipeline.

Beyond the preview

Go deeper on Yunnan Yongzitang Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunnan Yongzitang Pharmaceutical Co., Ltd..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call